Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Endoluminal stents for iliac and infrainguinal arterial disease

Información

DOI:
https://doi.org/10.1002/14651858.CD006644.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 abril 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Vascular

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Andrew Walker

    Department of Radiology, Royal Infirmary of Edinburgh, Edinburgh, UK

  • Kosmas I Paraskevas

    Northern Vascular Centre, Freeman Hospital, Newcastle upon Tyne, UK

  • Gerard Stansby

    Northern Vascular Centre, Freeman Hospital, Newcastle upon Tyne, UK

  • Peng F Wong

    Correspondencia a: Department of Vascular Surgery, James Cook University Hospital, Middlesbrough, UK

    [email protected]

Contributions of authors

All authors contributed to the text of the protocol.
AW will select and assess trials for inclusion, extract data and contribute to the text of the review.
KP will select and assess trials for inclusion, extract data and contribute to the text of the review.
GS and PW will resolve any differences in the selection and assessment of trials and the data extraction, and contribute to the text of the review.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Chief Scientist Office, Scottish Government Health Directorates, The Scottish Government, UK.

    The Cochrane Vascular editorial base is supported by the Chief Scientist Office.

  • National Institute for Health Research (NIHR), UK.

    This project was supported by the NIHR, via Cochrane Programme funding to Cochrane Vascular (10/4001/14). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Declarations of interest

AW: none known
KP: none known
GS: none known
PW: the author's institution received sponsorship from Gore Medical to facilitate travelling expenses for PW to attend a Vascular Society meeting in November 2015.

Version history

Published

Title

Stage

Authors

Version

2017 Apr 20

Endoluminal stents for iliac and infrainguinal arterial disease

Protocol

Andrew Walker, Kosmas I Paraskevas, Gerard Stansby, Peng F Wong

https://doi.org/10.1002/14651858.CD006644.pub2

2007 Jul 18

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease

Protocol

Benjamin Chua, Peter Robless, Gerard P Stansby

https://doi.org/10.1002/14651858.CD006644

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Table 1. Example 'Summary of findings' table

Bare metal stent compared with covered stent for restoration of patency in iliac artery occlusion or stenosis

Patient or population: people with iliac artery occlusion or stenosis

Settings: hospital

Intervention: bare metal stent

Comparison: covered stent

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Covered stent

Bare metal stent

Primary unassisted vessel patency failure

[follow‐up]

Study population

RR

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

[value] per 1000

[value] per 1000
([value] to [value])

Primary assisted patency

[follow‐up]

Study population

RR

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

[value] per 1000

[value] per 1000
([value] to [value])

Secondary patency

[follow‐up]

Study population

RR

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

[value] per 1000

[value] per 1000
([value] to [value])

Quality of life parameter

[range of scale or scale description]

[follow‐up]

The mean quality of life parameter ranged across control groups from
[value][measure]

The mean quality of life parameter in the intervention groups was
[value] [lower/higher]
[(value to value lower/higher)]

⊕⊝⊝⊝
very low

⊕⊕⊝⊝
low

⊕⊕⊕⊝
moderate

⊕⊕⊕⊕
high

*The basis for the assumed risk is the average risk in the covered stent group (i.e. the number of participants with events divided by total number of participants of the covered stent group included in the meta‐analysis). The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Figuras y tablas -
Table 1. Example 'Summary of findings' table
Ir a la tabla del protocolo